Huntington National Bank Continues to Hold Stake in athenahealth Inc. (ATHN)
Huntington National Bank maintained its position in athenahealth Inc. (NASDAQ:ATHN) during the second quarter, Holdings Channel reports. The institutional investor owned 47,064 shares of the company’s stock at the end of the second quarter. Huntington National Bank owned 0.12% of athenahealth worth $5,619,000 at the end of the most recent reporting period.
Other institutional investors have also recently added to or reduced their stakes in the company. Stifel Financial Corp raised its position in athenahealth by 14.3% in the fourth quarter. Stifel Financial Corp now owns 12,774 shares of the company’s stock worth $2,056,000 after buying an additional 1,603 shares during the period. Norges Bank bought a new stake in shares of athenahealth during the fourth quarter valued at about $48,571,000. Glenmede Trust Co. NA raised its stake in shares of athenahealth by 66.3% in the first quarter. Glenmede Trust Co. NA now owns 6,253 shares of the company’s stock valued at $867,000 after buying an additional 2,492 shares during the last quarter. Aperio Group LLC raised its stake in shares of athenahealth by 11.6% in the first quarter. Aperio Group LLC now owns 3,429 shares of the company’s stock valued at $476,000 after buying an additional 357 shares during the last quarter. Finally, Pacad Investment Ltd. bought a new stake in shares of athenahealth during the first quarter valued at about $222,000.
Shares of athenahealth Inc. (NASDAQ:ATHN) traded down 1.10% on Tuesday, hitting $121.03. 242,361 shares of the company traded hands. athenahealth Inc. has a 1-year low of $114.59 and a 1-year high of $170.42. The firm’s 50 day moving average price is $123.26 and its 200-day moving average price is $130.77. The stock has a market capitalization of $4.76 billion, a price-to-earnings ratio of 444.96 and a beta of 1.15.
athenahealth (NASDAQ:ATHN) last released its earnings results on Thursday, July 21st. The company reported $0.34 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.42 by $0.08. The firm earned $261.90 million during the quarter, compared to analysts’ expectations of $274.07 million. athenahealth had a return on equity of 5.16% and a net margin of 1.06%. On average, equities research analysts expect that athenahealth Inc. will post $1.75 earnings per share for the current year.
Several equities research analysts have issued reports on the stock. Zacks Investment Research lowered shares of athenahealth from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 12th. FBR & Co dropped their target price on shares of athenahealth from $145.00 to $140.00 and set a “market perform” rating for the company in a research report on Friday, July 22nd. Deutsche Bank AG lowered shares of athenahealth from a “buy” rating to a “hold” rating and dropped their target price for the company from $165.00 to $147.00 in a research report on Friday, July 22nd. Canaccord Genuity reiterated a “hold” rating and set a $142.00 target price on shares of athenahealth in a research report on Wednesday, June 29th. Finally, Leerink Swann reiterated a “hold” rating on shares of athenahealth in a research report on Thursday, June 16th. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and eight have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $149.58.
In other athenahealth news, CEO Jonathan Bush sold 4,000 shares of the company’s stock in a transaction that occurred on Friday, July 1st. The stock was sold at an average price of $138.21, for a total value of $552,840.00. Following the completion of the transaction, the chief executive officer now directly owns 312,109 shares in the company, valued at approximately $43,136,584.89. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Karl Stubelis sold 928 shares of the company’s stock in a transaction that occurred on Wednesday, September 7th. The stock was sold at an average price of $123.36, for a total value of $114,478.08. Following the completion of the transaction, the vice president now owns 1,375 shares of the company’s stock, valued at $169,620. The disclosure for this sale can be found here. 3.04% of the stock is currently owned by corporate insiders.
athenahealth Company Profile
athenahealth, Inc is a provider of cloud-based services and mobile applications for medical groups and health systems. The Company delivers cloud-based services for revenue cycle management and medical billing, electronic health records (EHR), patient engagement, care coordination, order transmission, population health management, and clinical decision support.
Want to see what other hedge funds are holding ATHN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for athenahealth Inc. (NASDAQ:ATHN).
Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.